Prostate cancer is the most commonly diagnosed cancer in males and the second leading cause of cancer-related death for men.

In order to diagnose this cancer a prostate biopsy is required and St John of God Bunbury Hospital Urologist Dr Paul Crow has commenced performing the new technique known as a transperineal biopsy.

“Transperineal biopsy can be advantageous as it accesses areas of the prostate that a standard prostate biopsy finds harder to reach and involves taking samples via the skin of the perineum, rather than through the rectal wall.

“Patients can receive a more accurate diagnosis and the technique reduces the risk of biopsy related infection, which can assist with recovery rates.

“This new biopsy technique adds to our existing comprehensive prostate cancer service that has also seen advances in the imaging techniques we can offer patients locally.”

St John of God Bunbury Chief Executive Officer Mr Jeffrey Williams said that the hospital was seeing an influx in the introduction of new technologies thanks to engaged doctors and funding from St John of God Foundation donors.

“Technology developments allow our team of specialist doctors, nurses and a multidisciplinary team to continue to provide a high quality prostate cancer service to locals in the South West of Western Australia.

“It is important that we stay abreast of new technologies, and we are fortunate that our doctors and clinical teams are challenging the status quo within their specialist fields.

“Our focus is always on what is best for our patients and they can rest assured that they are receiving the best treatment for their condition without having to travel to the city.”

The transperineal prostate biopsy equipment was funded by generous support from St John of God Foundation donors, providing cancer care closer to home for regional patients.

The 145-bed St John of God Bunbury Hospital is co-located with the Bunbury Regional Hospital and cares for private patients across the South West of Western Australia.